[{"immunocommentid":1,"comment":"The Immunochemistry test(s) have been developed and performance characteristics determined by Yellowstone Pathology Institute, Inc.  It has not been cleared or approved by the U.S. Food and Drug Administration.  The FDA has determined that such clearance or approval is not necessary.  This test is used for clinical purposes.  It should not be regarded as investigational or for research.  This laboratory is certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA-88) as qualified to perform high complexity clinical laboratory testing.\r\n","objectId":"55438e2f343932004a00025b","timestamp":"2017-02-16T19:15:42.831Z"},{"immunocommentid":2,"comment":"The estrogen (ER) and progesterone (PR) immunohistochemical assays were performed in paraffin embedded tissue with the ER (SP1) and PR (SP42) rabbit monoclonal antibodies.  The test was performed according to ASCO/CAP guidelines.","objectId":"55438e2f343932004a00025c","timestamp":"2017-02-16T19:15:42.831Z"},{"immunocommentid":4,"comment":"EGFR immunohistochemistry was performed on formalin-fixed, paraffin-embedded tissue sections using antibody clone 3C6 with Ventana ConfirmTM proprietary detection kit.  Status is scored as positive or negative based on the presence of any cellular reactivity.","objectId":"55438e2f343932004a00025d","timestamp":"2017-02-16T19:15:42.841Z"},{"immunocommentid":5,"comment":"CD117 immunohistochemistry was performed on formalin-fixed, paraffin-embedded tissue sections using Cell MarqueTM c-kit (polyclonal).  Status is scored as positive or negative based on the presence of any cellular reactivity.","objectId":"55438e2f343932004a00025e","timestamp":"2017-02-16T19:15:42.844Z"}]